Whanin makes a leap to be an advancing company
that leads a healthy society,
| Category | Code | Target Disease | Exploration | Research | Preclinical | Clinical Phase 1 |
Clinical Phase 2 |
Clinical Phase 3 |
Drug Approval |
|---|---|---|---|---|---|---|---|---|---|
| New Drugs | WID-2101 | Parkinson’s |
|
||||||
| WID-2301 | Parkinson’s |
|
|||||||
| WII-2201 | Dementia |
|
|||||||
| IMD | WIL-1901 | Dementia |
|
||||||
| WIP-2401 | Depression |
|
|||||||
| Specialty Generics | WIT-2001 | Parkinson’s |
|
||||||
| WIL-1903 | Alcohol Dependence |
|
|||||||
| WIG-2204 | Gastroesophageal Reflux Disease |
|
|||||||
| Generic | WIG-2207 | Gastroesophageal Reflux Disease |
|
||||||
| WIE-2301 | Essential hypertension |
|
|||||||
| WIE-2302 | Essential hypertension |
|
|||||||
| WIE-2303 | Gastric ulcer |
|
|||||||
| WIG-2201 | Dementia |
|
|||||||
| WIG-2202 | Epilepsy |
|
|||||||
| WIG-2203 | Dementia |
|
|||||||
| WIG-2206 | Dementia |
|
|||||||
| WIG-2303 | Dementia |
|
|||||||
| WIG-2401 | ADHD |
|
|||||||
| WIG-2404 | Depression |
|
